A Pityrosporum Fungal Infection Following Infliximab Therapy in a Crohn's Disease Patient
Intestinal Research
;
: 177-180, 2010.
Article
in English
| WPRIM
| ID: wpr-174476
ABSTRACT
Crohn's disease (CD) is a chronic immune-mediated inflammatory disorder. Treatment strategies for CD are targeted toward various components of the proinflammatory mediators and subsequent immune response. Recently, the anti-tumor necrosis factor (TNF) monoclonal antibody, infliximab has been used in patients with CD. However, uncommon and unusual infections have been reported during anti-TNF-alpha therapy and immunomodulator. Here, we report a case of pityriasis versicolor occurring in a patient with CD receiving infliximab treatment. The patient was successfully treated with topical ketoconazole.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Tinea Versicolor
/
Crohn Disease
/
Infliximab
/
Ketoconazole
/
Malassezia
/
Antibodies, Monoclonal
/
Necrosis
Limits:
Humans
Language:
English
Journal:
Intestinal Research
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS